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In the hippocampus, estrogens are powerful modulators of neurotransmission, synaptic plasticity and 29 neurogenesis. In women, menopause is associated with increased risk of memory disturbances, which 30 can be attenuated by timely estrogen therapy. In animal models of menopause, 17-estradiol (E2) 31 replacement improves hippocampus-dependent spatial memory. Here, we explored the effect of E2 32 replacement on hippocampal gene expression in a rat menopause model. Middle-aged ovariectomized 33 female rats were treated continuously for 29 days with E2 and then, the hippocampal transcriptome 34 was investigated with Affymetrix expression arrays. Microarray data were analyzed by Bioconductor 35 packages and web-based softwares, and verified with quantitative PCR. At standard fold change (FC) 36 selection criterion, 156 genes responded to E2. All alterations but four were transcriptional activation.
37
Robust activation (FC>10) occurred in the case of transthyretin, klotho, claudin 2, prolactin receptor, 38 ectodin, coagulation factor V, insulin-like growth factor 2, Igfbp2 and sodium/sulfate symporter.
39
Classification of the 156 genes revealed major groups including signaling (35 genes), metabolism (31 40 genes), extracellular matrix (17 genes) and transcription (16 genes). We selected 33 genes for further 41 studies and all changes were confirmed by real-time PCR. The results suggest that E2 promotes
Introduction
50
The hippocampus plays a pivotal role in learning and memory (1). Gonadal steroids, including 17-51 estradiol (E2), are powerful modulators of the hippocampal functions (2-4). Accordingly, E2 shapes 52 dendritic spine density of principal neurons during the estrous cycle (5), modulates neurogenesis (6,7), 53 alters neurotransmission (8), provides neuroprotection (9,10) and regulates the innate immune system 54 (11, 12) . In women, menopause is associated with increased risk of hippocampal decline and memory 55 disturbances (13, 14) . Estrogen replacement therapy (ERT) is effective in some, but not all women to 56 attenuate menopause-related memory disturbances. The effects of ERT on hippocampus and memory 57 are complex, and the effects depend on many parameters including estrogen responsiveness of the 58 individual, the chemical structure of the active estrogen compound, dosage and initiation of treatment,
59
among others (15). It has been proposed that a critical period exists for beneficial estrogen effects (16-60 18) . In accord with the hypothesis, perimenopausal and early postmenopausal hormone therapies are 61 often associated with improved cognitive functions later in life (19) (20) (21) (22) . However, the clinical practice 62 lacks an effective ERT to treat menopause-related decline of cognitive performance.
63
E2 improves some aspects of cognitive performance in many rat studies. In young 64 ovariectomized (OVX) female rats, E2 replacement (29 pg/mL of serum E2) increases working 65 memory (23). In another study, E2 replacements (25 and 50 pg/mL of serum E2) enhance spatial 66 memory, and improve adaptation to increasing amounts of working memory information (24). In the 67 case of high memory demand, high-dose E2-replaced animals even outperform intact cycling females 68 (24) . The middle-aged OVX rat (25) is a widely used rodent model of menopause. In this model,
69
immediate E2 replacement (20-25 pg/mL of serum E2) following OVX enhances acquisition during a 70 working memory task, but treatment several month after OVX was ineffective (26). Orally 71 administered E2 improves spatial memory, but E2 plus medroxyprogesterone-acetate treatment 72 impairs performance (27) . Additional studies also find that E2 improves hippocampus-dependent 73 spatial memory (28) (29) (30) (31) . Current studies from the Daniel laboratory show that transient exposure of E2 74 after OVX (37 pg/mL of serum E2 levels) provides enduring benefits on the hippocampus and 75 memory (32, 33) . Although many animal studies have demonstrated the positive effect of E2 on 76 cognitive performance, it should be noted that the effects are moderate and not all studies have found 77 beneficial effects.
78
E2 exerts genomic nuclear actions (34) and nongenomic membrane actions (35). We 79 hypothesize that genomic effects contribute to the impact of E2 on the hippocampus. Estrogen 80 receptor-alpha (ER), ER and GPR30 are expressed in the rat hippocampus at mRNA and protein 81 levels (36) (37) (38) . Genomic effects change with age which is partly due to the altered ratio of the ER 82 and ER subtypes (39). Relatively little information is currently available on the impact of E2 on 83 hippocampal gene expression, and a comprehensive list of E2 regulated genes is still missing from the 84 public domain. Therefore, elucidation of E2 target genes and estrogen driven regulatory mechanisms 85 await further clarification. In this study, we identified 156 E2-regulated genes in middle-aged OVX 86 rats and proposed major downstream regulatory mechanisms of E2 action, which underlie its impact 87 on hippocampal functions of postmenopausal females. replaced group to the vehicle-treated one. Studies, which were performed in our animal facility, 100 provided evidence that separate housing does not change basal corticosterone levels in rats (41). At 101 their age of 13 months, the rats were deeply anesthetized and OVX bilaterally. Afterward, they were 102 kept on phytoestrogen-free diet (Harlan Teklad Global Diets, Madison, WI 
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Materials and Methods
Results
144
Oligonucleotide microarray revealed robust transcriptional activation in the hippocampus after
145
E2 replacement
146
Two hundred and sixty-two transcripts showed the absolute FC higher than 1.5, which we 147 considered as a criterion of E2 responsiveness. The 256 activated and 6 suppressed transcripts 148 included 152 and 4 protein coding genes, respectively (Supplemental Table 1 ). The rest, 106 149 transcripts without currently known protein products, was not analyzed further. The heat map shows 150 mRNA level of the top differentially expressed genes in the hippocampus of 4 vehicle-and 4 E2-151 treated OVX animals ( Fig. 1) . It shows small variability within treatment groups. As the color code 152 indicates dark green, light green and orange represent very low, slight and moderate mRNA levels,
153
respectively. The heat map shows a green to orange/red transition from left to right in color pattern 154 illustrating the robust transcriptional activation in response to E2, as the leading trend.
155
Nine genes, including transthyretin (Ttr), klotho (Kl), claudin (Cldn2), prolactin receptor 156 (Prlr), ectodin/wise (Sostdc1), coagulation factor V (F5), insulin-like growth factor 2 (Igf2), IGF binding protein (Igfbp2) and sodium/sulfate symporter (Slc13a4) showed the most robust increase 158 (FC>10) in mRNA expression. We termed these prime E2 target genes ( Table 1) .
159
Twelve genes showed considerable activation of transcription (10>FC>4) and encoded folate 160 receptor (Folr1),  type I collagen (Col1a2), HT 2C receptor (Htr2c), secreted frizzled-related protein 161 (Sfrp1),  type VIII collagen (Col8a2), membrane frizzled-related protein (Mfrp),  type III collagen 162 (Col3a1), orthodenticle homeobox (Otx2), angiotensin-converting enzyme (Ace), midkine (Mdk), 163 ectonucleotide phosphodiesterase family member 2/autotaxin (Enpp2) and  type I collagen (Col1a1).
164
We named these substantial E2 target genes ( Table 1) .
165
Forty genes showed moderate (4>FC>2) activation (Supplemental Table 1 
252
Due to our special interest and their significant role in hippocampal regulation, we studied the 253 putative estrogenic regulation of additional genes. The PCR study revealed that corticotropin releasing 254 hormone receptor 2 (Crhr2), serum and glucocorticoid-regulated kinase 1 (Sgk1), Na-K-Cl 255 cotransporter (Slc12a2), vesicular glutamate transporter 1 (Slc17a7) and vesicular inhibitory amino 256 acid transporter (Slc32a1) were regulated by E2 ( Table 2) .
258
Discussion
259
In animal models of menopause, E2 exposure exerts a strong and enduring impact on hippocampal 260 functions, but the underlying mechanisms remain elusive. In this study, we compared the hippocampal 261 transcriptomes of middle-aged, OVX E2-replaced and vehicle-treated rats, and identified 156 estrogen 262 responsive genes. We conclude that in middle-aged, gonadal steroid deficient female rats i) the 263 hippocampal transcriptome is highly responsive to E2; ii) major E2 target genes include Ttr, Kl, 264 Cldn2, Prlr, Sostdc1, Igf2, Igfbp2, Folr1, Htr2c, Sfrp1, Otx2, Ace, Mdk and Enpp2; iii) 
285
Immune related changes were similar in the frontal cortex (48) 
321
In the brain, the expression of klotho decreases with age (67). We found that E2 robustly increases 322 klotho expression which may promote anti-aging klotho signaling. Our finding is the first evidence 323 that klotho is a prime E2 target gene. (Fig. 3) . We propose that activation of the above mentioned mechanisms 468 contributes to the improvement of hippocampus-dependent memory performance after chronic 469 administration of E2 in middle-aged OVX rats (26, 27, (30) (31) (32) In data analysis we applied the standard selection criterion of absolute FC>1. Zic family member 1 Zic4
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